1. Advisory to Drug Manufacturers: Formation of Glass Lamellae in Certain Injectable Drugs, 2011.
2. Evaluation of Glass Delamination Risk in Pharmaceutical 10 mL/10R Vials;Ditter;J. Pharm. Sci.,2017
3. Glass vials for small volume parenterals: influence of drug and manufacturing processes on glass delamination;Ennis;Pharm. Dev. Technol.,2001
4. FDA, 2003. Guidance for Industry Q1A(R2) Stability Testing of New Drug Substances and Products. US FDA Retrieved from https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
5. Green, D. (Producer), 2012. Glass Delamination: Background and Regulatory Prospective [Powerpoint Presentation].